Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director · President, CEO and Chair | March 31, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date March 31, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (RSUs)SEC Table I · non-derivative | Direct | 160,860 |
Reported balance
After 2026-03-31 transaction · row 1
1 source rowRow 1 · 2026-03-31 · Grant · Acquired 86,326 · Balance 160,860 F1: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. |
| Common StockSEC Table I · non-derivative | Direct | 70,349 |
Reported balance
After 2026-04-01 transaction · row 2
1 source rowRow 2 · 2026-04-01 · Tax withholding · Disposed 8,029 · Balance 70,349 F2: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.
F2: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 2, 2026 20:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 8,029 | $72.49 | $582,022.21 |
DisclosureSEC source: 0000064803-26-000038 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · Director · President, CEO and Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,349 F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (RSUs) | 86,326 | $71.82 | $6,199,933.32 |
DisclosureSEC source: 0000064803-26-000038 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · Director · President, CEO and Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,860 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. Read SEC document |
| February 28, 2026 Filed Mar 2, 2026 22:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,944 | $79.90 | $155,325.60 |
DisclosureSEC source: 0000064803-26-000012 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,996 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 226,138 | $67.98 Strike: $67.98 | $15,372,861.24 |
DisclosureSEC source: 0001127602-25-011405 · form4.xml · derivative · entry 2 Joyner J. David · CIK 0001515598 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,138 Underlying: Common Stock · 226,138 shares Expires 2035-04-01 F2 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2026. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,847 | $67.98 | $125,559.06 |
DisclosureSEC source: 0001127602-25-011405 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,940 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| April 01, 2025 Filed May 9, 2025 20:32 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (RSUs) | 53,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013864 · form4a.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,515 F1 · security: The purpose of this amendment is to correct the number and type of derivative securities granted to the reporting person on April 1, 2025, which was originally reported on a Form 4 filed on April 3, 2025 (the "Initial Form 4"). The Initial Form 4 incorrectly reported that the reporting person was granted stock options. As reported in this amendment, the reporting person was granted 53,324 restricted stock units ("RSUs"), awarded pursuant to Issuer's 2017 Incentive Compensation Plan, and not 226,138 stock options, as reported in the Initial Form 4. Restrictions on the RSUs lapse in four equal annual installments, commencing 4/1/2026. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,944 | $65.72 | $127,759.68 |
DisclosureSEC source: 0001127602-25-007556 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,717 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| November 30, 2024 Filed Dec 3, 2024 22:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantPremium Stock Option · Derivative | 1,492,537 | $71.82 Strike: $71.82 | $107,194,007.34 |
DisclosureSEC source: 0001127602-24-028488 · form4.xml · derivative · entry 4 Joyner J. David · CIK 0001515598 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,492,537 Underlying: Common Stock · 1,492,537 shares Expires 2031-11-30 F2 · security: Option becomes exercisable in three equal annual installments, commencing 11/30/2025. Read SEC document |
| November 30, 2024 Filed Dec 26, 2024 21:11 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantPremium Stock Appreciation Right · Derivative | 492,537 | $71.82 Strike: $71.82 | $35,374,007.34 |
DisclosureSEC source: 0001127602-24-030049 · form4a.xml · derivative · entry 4 Joyner J. David · CIK 0001515598 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,537 Underlying: Common Stock · 492,537 shares Expires 2031-11-30 F1 · security: On December 20, 2024, the Issuer made certain administrative modifications to the Reporting Person's November 30, 2024 grant agreement, confirming that the Reporting Person was granted a stock option to acquire 1,000,000 shares of Issuer common stock and a stock-settled stock appreciation right ("SAR") with respect to 492,537 shares of Issuer common stock, each at a premium exercise or grant price, as applicable, of $71.82. Both the option and the SAR become exercisable in three equal annual installments, with the first installment vesting on November 30, 2025. No change was made to the aggregate grant date value of the award, as reflected in the original Form 4 filed by the Reporting Person on December 3, 2024. Read SEC document |
| November 30, 2024 Filed Dec 26, 2024 21:11 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantPremium Stock Option · Derivative | 1,000,000 | $71.82 Strike: $71.82 | $71,820,000.00 |
DisclosureSEC source: 0001127602-24-030049 · form4a.xml · derivative · entry 3 Joyner J. David · CIK 0001515598 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2031-11-30 F1 · security: On December 20, 2024, the Issuer made certain administrative modifications to the Reporting Person's November 30, 2024 grant agreement, confirming that the Reporting Person was granted a stock option to acquire 1,000,000 shares of Issuer common stock and a stock-settled stock appreciation right ("SAR") with respect to 492,537 shares of Issuer common stock, each at a premium exercise or grant price, as applicable, of $71.82. Both the option and the SAR become exercisable in three equal annual installments, with the first installment vesting on November 30, 2025. No change was made to the aggregate grant date value of the award, as reflected in the original Form 4 filed by the Reporting Person on December 3, 2024. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 28,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012266 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP&President-PharmacyServices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,241 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,970 | $75.19 | $148,124.30 |
DisclosureSEC source: 0001127602-24-007929 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP&President-PharmacyServices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,681 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 51,959 | $74.31 Strike: $74.31 | $3,861,073.29 |
DisclosureSEC source: 0001127602-23-012234 · form4.xml · derivative · entry 3 Joyner J. David · CIK 0001515598 · EVP&President-PharmacyServices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,959 Underlying: Common Stock · 51,959 shares Expires 2033-04-01 F1 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 23,940 | $83.54 | $1,999,947.60 |
DisclosureSEC source: 0001127602-23-007953 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,940 F1 · kind: Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 2/28/2024. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 35,062 | $78.05 Strike: $78.05 | $2,736,589.10 |
DisclosureSEC source: 0001127602-17-014082 · form4.xml · derivative · entry 4 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,062 Underlying: Common Stock · 35,062 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,484 | $78.05 | $349,976.20 |
DisclosureSEC source: 0001127602-17-014082 · form4.xml · nonDerivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,015 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,862 | $78.50 | $146,167.00 |
DisclosureSEC source: 0001127602-17-014082 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,601 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 847 | $78.50 | $66,489.50 |
DisclosureSEC source: 0001127602-17-014082 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,463 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,705 | $80.58 | $137,388.90 |
DisclosureSEC source: 0001127602-17-009785 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,853 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 6,205 | $80.58 | $499,998.90 |
DisclosureSEC source: 0001127602-17-009785 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,558 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 25,093 | $104.82 Strike: $104.82 | $2,630,248.26 |
DisclosureSEC source: 0001127602-16-048898 · form4.xml · derivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,093 Underlying: Common Stock · 25,093 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 3,339 | $104.82 | $349,993.98 |
DisclosureSEC source: 0001127602-16-048898 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,988 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,155 | $104.82 | $121,067.10 |
DisclosureSEC source: 0001127602-16-048898 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,353 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 5,582 | $97.17 | $542,402.94 |
DisclosureSEC source: 0001127602-16-044590 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,757 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,862 | $102.71 | $191,246.02 |
DisclosureSEC source: 0001127602-15-013957 · form4.xml · nonDerivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,175 F3 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 23,968 | $102.26 Strike: $102.26 | $2,450,967.68 |
DisclosureSEC source: 0001127602-15-013957 · form4.xml · derivative · entry 4 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,968 Underlying: Common Stock · 23,968 shares Expires 2022-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 3,422 | $102.26 | $349,933.72 |
DisclosureSEC source: 0001127602-15-013957 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,400 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,801 | $102.26 | $184,170.26 |
DisclosureSEC source: 0001127602-15-013957 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,599 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 6,017 | $103.87 | $624,985.79 |
DisclosureSEC source: 0001127602-15-009655 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,109 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 07, 2015 Filed Feb 10, 2015 21:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 263 | $100.61 | $26,460.43 |
DisclosureSEC source: 0001127602-15-005280 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,092 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| August 06, 2014 Filed Aug 7, 2014 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 45,897 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-14-024946 · form4.xml · derivative · entry 7 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,897 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| August 06, 2014 Filed Aug 7, 2014 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 77,619 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-14-024946 · form4.xml · derivative · entry 6 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 77,619 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| August 06, 2014 Filed Aug 7, 2014 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 45,897 | $76.10 | $3,492,761.70 |
DisclosureSEC source: 0001127602-14-024946 · form4.xml · nonDerivative · entry 4 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,399 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $76.00 and $76.50 per share. Read SEC document |
| August 06, 2014 Filed Aug 7, 2014 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 45,897 | $36.23 | $1,662,848.31 |
DisclosureSEC source: 0001127602-14-024946 · form4.xml · nonDerivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2014 Filed Aug 7, 2014 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 77,619 | $76.10 | $5,906,805.90 |
DisclosureSEC source: 0001127602-14-024946 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,399 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $76.00 and $76.50 per share. Read SEC document |
| August 06, 2014 Filed Aug 7, 2014 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 77,619 | $28.10 | $2,181,093.90 |
DisclosureSEC source: 0001127602-14-024946 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 25,177 | $74.29 Strike: $74.29 | $1,870,399.33 |
DisclosureSEC source: 0001127602-14-014001 · form4.xml · derivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,177 Underlying: Common Stock · 25,177 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,038 | $74.29 | $299,983.02 |
DisclosureSEC source: 0001127602-14-014001 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,663 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 9,203 | $74.29 | $683,690.87 |
DisclosureSEC source: 0001127602-14-014001 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,399 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,844 | $70.32 | $199,990.08 |
DisclosureSEC source: 0001127602-14-007474 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,667 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 15, 2014 Filed Feb 18, 2014 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 527 | $69.90 | $36,837.30 |
DisclosureSEC source: 0001127602-14-006767 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,823 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 07, 2014 Filed Feb 10, 2014 21:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 402 | $66.44 | $26,708.88 |
DisclosureSEC source: 0001127602-14-005381 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,094 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 95,135 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0001127602-14-001018 · form4.xml · derivative · entry 7 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 95,135 shares Expires 2015-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 125,250 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0001127602-14-001018 · form4.xml · derivative · entry 6 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,250 shares Expires 2014-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 95,135 | $70.47 | $6,704,163.45 |
DisclosureSEC source: 0001127602-14-001018 · form4.xml · nonDerivative · entry 4 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,540 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.27 and $70.75 per share. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 95,135 | $41.17 | $3,916,707.95 |
DisclosureSEC source: 0001127602-14-001018 · form4.xml · nonDerivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 125,250 | $70.50 | $8,830,125.00 |
DisclosureSEC source: 0001127602-14-001018 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,540 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.26 and $70.75 per share. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 125,250 | $34.42 | $4,311,105.00 |
DisclosureSEC source: 0001127602-14-001018 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 23,604 | $54.53 Strike: $54.53 | $1,287,126.12 |
DisclosureSEC source: 0001127602-13-013289 · form4.xml · derivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,604 Underlying: Common Stock · 23,604 shares Expires 2020-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,342 | $54.53 | $127,709.26 |
DisclosureSEC source: 0001127602-13-013289 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,540 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.